Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):211-213. doi: 10.18176/jiaci.0831. Epub 2022 Jun 7.
No abstract available

Keywords: Atopic dermatitis; Atopic eczema; JAK-inhibitors; Real-world evidence; Upadacitinib.

MeSH terms

  • Dermatitis, Atopic* / diagnosis
  • Dermatitis, Atopic* / drug therapy
  • Heterocyclic Compounds, 3-Ring
  • Humans
  • Treatment Outcome

Substances

  • upadacitinib
  • Heterocyclic Compounds, 3-Ring